Medicure (OTCMKTS:MCUJF) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Medicure (OTCMKTS:MCUJF) released its quarterly earnings data on Thursday. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.01, Zacks reports. The business had revenue of $5.79 million for the quarter, compared to analyst estimates of $3.63 million. Medicure had a negative return on equity of 42.01% and a negative net margin of 21.65%.

Medicure Stock Performance

OTCMKTS MCUJF opened at $0.80 on Friday. The firm has a market capitalization of $8.39 million, a P/E ratio of -1.71 and a beta of 0.97. Medicure has a 1-year low of $0.68 and a 1-year high of $0.97. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.02 and a quick ratio of 0.77. The business’s 50-day simple moving average is $0.83 and its 200-day simple moving average is $0.84.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.